• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Timing of Early Antibiotics and Hospital Mortality in Sepsis.脓毒症中早期使用抗生素的时机与医院死亡率
Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863. doi: 10.1164/rccm.201609-1848OC.
2
Delayed Second Dose Antibiotics for Patients Admitted From the Emergency Department With Sepsis: Prevalence, Risk Factors, and Outcomes.急诊科收治的脓毒症患者延迟使用第二剂抗生素:患病率、危险因素及结局
Crit Care Med. 2017 Jun;45(6):956-965. doi: 10.1097/CCM.0000000000002377.
3
The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.抗生素使用时机对严重脓毒症和脓毒性休克预后的影响:一项系统评价和Meta分析
Crit Care Med. 2015 Sep;43(9):1907-15. doi: 10.1097/CCM.0000000000001142.
4
Delays to Antibiotics in the Emergency Department and Risk of Mortality in Children With Sepsis.急诊科抗生素使用延迟与脓毒症患儿死亡风险的关系。
JAMA Netw Open. 2024 Jun 3;7(6):e2413955. doi: 10.1001/jamanetworkopen.2024.13955.
5
INITIAT-E.D.: Impact of timing of INITIation of Antibiotic Therapy on mortality of patients presenting to an Emergency Department with sepsis.抗生素治疗起始时机对因脓毒症就诊于急诊科患者死亡率的影响。
Emerg Med Australas. 2015 Jun;27(3):196-201. doi: 10.1111/1742-6723.12394. Epub 2015 Apr 6.
6
The DISPARITY-II study: delays to antibiotic administration in women with severe sepsis or septic shock.DISPARITY-II研究:重症脓毒症或脓毒性休克女性患者抗生素给药延迟情况
Acad Emerg Med. 2014 Dec;21(12):1499-502. doi: 10.1111/acem.12546. Epub 2014 Nov 25.
7
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.经验性抗生素治疗从第一小时起即可降低严重脓毒症和脓毒性休克的死亡率:基于指南的绩效改进项目结果
Crit Care Med. 2014 Aug;42(8):1749-55. doi: 10.1097/CCM.0000000000000330.
8
The Association Between Antibiotic Delay Intervals and Hospital Mortality Among Patients Treated in the Emergency Department for Suspected Sepsis.抗生素延迟时间与急诊科疑似脓毒症患者住院死亡率的相关性研究。
Crit Care Med. 2021 May 1;49(5):741-747. doi: 10.1097/CCM.0000000000004863.
9
First-to-second antibiotic delay and hospital mortality among emergency department patients with suspected sepsis.疑似脓毒症的急诊科患者中首次抗生素使用到开始使用抗生素之间的时间延迟与住院死亡率的关系。
Am J Emerg Med. 2021 Aug;46:20-22. doi: 10.1016/j.ajem.2021.02.059. Epub 2021 Mar 2.
10
Delays From First Medical Contact to Antibiotic Administration for Sepsis.从首次医疗接触到脓毒症患者使用抗生素的延迟情况。
Crit Care Med. 2017 May;45(5):759-765. doi: 10.1097/CCM.0000000000002264.

引用本文的文献

1
Comparison of the Reverse Shock Index Multiplied by Glasgow Coma Scale Score, MEWS, and qSOFA as Sepsis Screening Tools for Predicting Short-Term Outcomes.将反向休克指数乘以格拉斯哥昏迷量表评分、改良早期预警评分(MEWS)和快速序贯器官衰竭评估(qSOFA)作为脓毒症筛查工具预测短期结局的比较
Open Access Emerg Med. 2025 Sep 2;17:247-255. doi: 10.2147/OAEM.S521868. eCollection 2025.
2
Exploring the Potentials of Artificial Intelligence in Sepsis Management in the Intensive Care Unit.探索人工智能在重症监护病房脓毒症管理中的潜力。
Crit Care Res Pract. 2025 Aug 28;2025:9031137. doi: 10.1155/ccrp/9031137. eCollection 2025.
3
TM9SF1 as a Novel Prognostic Biomarker for Sepsis Severity and Mortality: A Longitudinal Study.TM9SF1作为脓毒症严重程度和死亡率的新型预后生物标志物:一项纵向研究
J Inflamm Res. 2025 Aug 25;18:11611-11626. doi: 10.2147/JIR.S527416. eCollection 2025.
4
Sepsis in burn care: incidence and outcomes.烧伤护理中的脓毒症:发病率与转归
Mil Med Res. 2025 Sep 1;12(1):55. doi: 10.1186/s40779-025-00643-x.
5
Optimizing Clinical Indicators in Hematologic Malignancies and Sepsis Using ddPCR: A Retrospective Study.使用数字滴度PCR优化血液系统恶性肿瘤和脓毒症的临床指标:一项回顾性研究
Infect Dis Ther. 2025 Aug 29. doi: 10.1007/s40121-025-01207-1.
6
[S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].[S3 脓毒症预防、诊断、治疗及随访指南 - 2025年更新版]
Med Klin Intensivmed Notfmed. 2025 Aug 18. doi: 10.1007/s00063-025-01317-1.
7
Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management.细菌大战:人工智能在脓毒症管理中卷土重来
Diagnostics (Basel). 2025 Jul 28;15(15):1890. doi: 10.3390/diagnostics15151890.
8
Rapid Access to Emergency Medical Services Within Historically Redlined Areas.在历史上划定的红线区域内快速获得紧急医疗服务。
JAMA Netw Open. 2025 Aug 1;8(8):e2525681. doi: 10.1001/jamanetworkopen.2025.25681.
9
Piperacillin/tazobactam Clearance Predicted by Non-Creatinine Based Estimates of GFR in Critically Ill Adults.基于非肌酐的肾小球滤过率估计值预测危重症成年患者哌拉西林/他唑巴坦清除率
Int J Antimicrob Agents. 2025 Aug 1:107586. doi: 10.1016/j.ijantimicag.2025.107586.
10
CitH3, a Druggable Biomarker for Human Diseases Associated with Acute NETosis and Chronic Immune Dysfunction.CitH3,一种与急性中性粒细胞胞外诱捕网形成及慢性免疫功能障碍相关的人类疾病的可药物靶向生物标志物。
Pharmaceutics. 2025 Jun 23;17(7):809. doi: 10.3390/pharmaceutics17070809.

本文引用的文献

1
The Natural History of Changes in Preferences for Life-Sustaining Treatments and Implications for Inpatient Mortality in Younger and Older Hospitalized Adults.维持生命治疗偏好变化的自然史及其对年轻和老年住院成年人住院死亡率的影响
J Am Geriatr Soc. 2016 May;64(5):981-9. doi: 10.1111/jgs.14048. Epub 2016 Apr 27.
2
Multicenter Implementation of a Treatment Bundle for Patients with Sepsis and Intermediate Lactate Values.针对脓毒症和中度乳酸值患者的治疗集束方案的多中心实施
Am J Respir Crit Care Med. 2016 Jun 1;193(11):1264-70. doi: 10.1164/rccm.201507-1489OC.
3
Septic Shock: Advances in Diagnosis and Treatment.脓毒性休克:诊断与治疗进展
JAMA. 2015 Aug 18;314(7):708-17. doi: 10.1001/jama.2015.7885.
4
The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.抗生素使用时机对严重脓毒症和脓毒性休克预后的影响:一项系统评价和Meta分析
Crit Care Med. 2015 Sep;43(9):1907-15. doi: 10.1097/CCM.0000000000001142.
5
A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.一项针对感染性休克早期目标导向治疗的系统评价和荟萃分析:ARISE、ProCESS 和 ProMISe 研究人员。
Intensive Care Med. 2015 Sep;41(9):1549-60. doi: 10.1007/s00134-015-3822-1. Epub 2015 May 8.
6
Sepsis: a roadmap for future research.脓毒症:未来研究的路线图。
Lancet Infect Dis. 2015 May;15(5):581-614. doi: 10.1016/S1473-3099(15)70112-X. Epub 2015 Apr 19.
7
The association between time to antibiotics and relevant clinical outcomes in emergency department patients with various stages of sepsis: a prospective multi-center study.急诊科不同脓毒症阶段患者使用抗生素的时间与相关临床结局之间的关联:一项前瞻性多中心研究。
Crit Care. 2015 Apr 29;19(1):194. doi: 10.1186/s13054-015-0936-3.
8
Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.脓毒症分类和多重耐药状态对接受适当治疗患者预后的影响。
Crit Care Med. 2015 Aug;43(8):1580-6. doi: 10.1097/CCM.0000000000001013.
9
INITIAT-E.D.: Impact of timing of INITIation of Antibiotic Therapy on mortality of patients presenting to an Emergency Department with sepsis.抗生素治疗起始时机对因脓毒症就诊于急诊科患者死亡率的影响。
Emerg Med Australas. 2015 Jun;27(3):196-201. doi: 10.1111/1742-6723.12394. Epub 2015 Apr 6.
10
Trial of early, goal-directed resuscitation for septic shock.早期目标导向性复苏治疗脓毒性休克的试验。
N Engl J Med. 2015 Apr 2;372(14):1301-11. doi: 10.1056/NEJMoa1500896. Epub 2015 Mar 17.

脓毒症中早期使用抗生素的时机与医院死亡率

The Timing of Early Antibiotics and Hospital Mortality in Sepsis.

作者信息

Liu Vincent X, Fielding-Singh Vikram, Greene John D, Baker Jennifer M, Iwashyna Theodore J, Bhattacharya Jay, Escobar Gabriel J

机构信息

1 Kaiser Permanente Division of Research, Oakland, California.

2 Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California.

出版信息

Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863. doi: 10.1164/rccm.201609-1848OC.

DOI:10.1164/rccm.201609-1848OC
PMID:28345952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649973/
Abstract

RATIONALE

Prior sepsis studies evaluating antibiotic timing have shown mixed results.

OBJECTIVES

To evaluate the association between antibiotic timing and mortality among patients with sepsis receiving antibiotics within 6 hours of emergency department registration.

METHODS

Retrospective study of 35,000 randomly selected inpatients with sepsis treated at 21 emergency departments between 2010 and 2013 in Northern California. The primary exposure was antibiotics given within 6 hours of emergency department registration. The primary outcome was adjusted in-hospital mortality. We used detailed physiologic data to quantify severity of illness within 1 hour of registration and logistic regression to estimate the odds of hospital mortality based on antibiotic timing and patient factors.

MEASUREMENTS AND MAIN RESULTS

The median time to antibiotic administration was 2.1 hours (interquartile range, 1.4-3.1 h). The adjusted odds ratio for hospital mortality based on each hour of delay in antibiotics after registration was 1.09 (95% confidence interval [CI], 1.05-1.13) for each elapsed hour between registration and antibiotic administration. The increase in absolute mortality associated with an hour's delay in antibiotic administration was 0.3% (95% CI, 0.01-0.6%; P = 0.04) for sepsis, 0.4% (95% CI, 0.1-0.8%; P = 0.02) for severe sepsis, and 1.8% (95% CI, 0.8-3.0%; P = 0.001) for shock.

CONCLUSIONS

In a large, contemporary, and multicenter sample of patients with sepsis in the emergency department, hourly delays in antibiotic administration were associated with increased odds of hospital mortality even among patients who received antibiotics within 6 hours. The odds increased within each sepsis severity strata, and the increased odds of mortality were greatest in septic shock.

摘要

理论依据

先前评估抗生素使用时机的脓毒症研究结果不一。

目的

评估在急诊科登记后6小时内接受抗生素治疗的脓毒症患者中,抗生素使用时机与死亡率之间的关联。

方法

对2010年至2013年期间在北加利福尼亚州21个急诊科接受治疗的35000例随机选择的脓毒症住院患者进行回顾性研究。主要暴露因素是在急诊科登记后6小时内给予抗生素。主要结局是校正后的院内死亡率。我们使用详细的生理数据在登记后1小时内量化疾病严重程度,并使用逻辑回归根据抗生素使用时机和患者因素估计医院死亡率的几率。

测量指标和主要结果

抗生素给药的中位时间为2.1小时(四分位间距,1.4 - 3.1小时)。登记后抗生素每延迟1小时,校正后的院内死亡率比值比为1.09(95%置信区间[CI],1.05 - 1.13),即登记与抗生素给药之间每经过1小时。抗生素给药延迟1小时,脓毒症患者的绝对死亡率增加0.3%(95%CI,0.01 - 0.6%;P = 0.04),严重脓毒症患者增加0.4%(95%CI,0.1 - 0.8%;P = 0.02),休克患者增加1.8%(95%CI,0.8 - 3.0%;P = 0.001)。

结论

在一个大型、当代且多中心的急诊科脓毒症患者样本中,即使在6小时内接受抗生素治疗的患者中,抗生素给药每延迟1小时,医院死亡率的几率也会增加。在每个脓毒症严重程度分层中几率均增加,且在感染性休克中死亡率增加的几率最大。